However, differential expression of SLC6A13 was observed in different groups according to the patient’s gender (Figure 2E), tumor grade (Figure 2G), Histological subtypes (Figure 2I), and TP53 mutation status (Figure 2J). This evidence concerns the gene TP53 and neoplasm.